Iovance Biotherapeutics reports inducement grants under Nasdaq Rule 5635(c)(4)
The company disclosed inducement grants made under Nasdaq Listing Rule 5635(c)(4), which typically relates to equity awards as part of hiring or recruitment arrangements.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.